Schwartz–Matsuo syndrome

From WikiMD's Food, Medicine & Wellness Encyclopedia

Schwartz–Matsuo syndrome is a rare medical condition characterized by retinal detachment and rhegmatogenous retinal detachment. The syndrome is named after the two doctors, Dr. Robert Schwartz and Dr. Hiroshi Matsuo, who first described the condition in 1990.

Symptoms[edit | edit source]

The primary symptom of Schwartz–Matsuo syndrome is retinal detachment, which can lead to vision loss if not treated promptly. Other symptoms may include flashes of light, floaters, and a dark curtain over the field of vision.

Causes[edit | edit source]

The exact cause of Schwartz–Matsuo syndrome is unknown. However, it is believed to be related to the presence of retinal holes or retinal tears, which allow fluid to accumulate behind the retina, leading to detachment.

Diagnosis[edit | edit source]

Diagnosis of Schwartz–Matsuo syndrome is typically made through a comprehensive eye examination, including a dilated eye exam and optical coherence tomography (OCT). Other diagnostic tests may include fluorescein angiography and ultrasound of the eye.

Treatment[edit | edit source]

Treatment for Schwartz–Matsuo syndrome typically involves surgery to repair the retinal detachment. This may include vitrectomy, scleral buckle surgery, or pneumatic retinopexy. In some cases, laser photocoagulation or cryotherapy may be used to seal retinal tears or holes.

Prognosis[edit | edit source]

The prognosis for Schwartz–Matsuo syndrome varies depending on the severity of the retinal detachment and the success of treatment. With prompt and appropriate treatment, vision can often be preserved or restored.

See also[edit | edit source]

References[edit | edit source]

Schwartz–Matsuo syndrome Resources
Doctor showing form.jpg
Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD